Investigating how certain brain chemicals affect fear memory in PTSD

The role of cerebellar endocannabinoids in the reconsolidation and extinction of fear memory

NIH-funded research Southeast Louisiana Veterans Health Care · NIH-10951490

This study is looking at how certain natural chemicals in the brain can help people with PTSD change their fear memories, with the hope of finding new ways to help those who haven't had success with regular treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSoutheast Louisiana Veterans Health Care NIH-funded
Lab location1 site (New Orleans, United States)
Project IDNIH-10951490 on NIH RePORTER

What this research studies

This research focuses on understanding how endocannabinoids in the cerebellum influence the processes of fear memory reconsolidation and extinction in individuals with post-traumatic stress disorder (PTSD). By exploring the mechanisms behind fear responses and how they can be modified, the study aims to identify new therapeutic approaches for patients who do not respond to traditional treatments. The methodology involves examining the brain's response to fear stimuli and testing potential interventions that could disrupt harmful fear memories. This could lead to innovative treatments that help patients learn to manage their fear responses more effectively.

Who could benefit from this research

Good fit: Ideal candidates for this research are veterans or individuals experiencing PTSD who struggle with persistent fear responses.

Not a fit: Patients without PTSD or those who do not have a history of trauma may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve the treatment of PTSD, particularly for those who have not benefited from existing methods.

How similar studies have performed: While there has been extensive research on fear memory and its treatment, this specific approach focusing on cerebellar endocannabinoids is relatively novel and has not been widely tested.

Where this research is happening

New Orleans, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.